Nelson Vergel
Founder, ExcelMale.com
[h=3][PDF] MP85-13 ERECTILE FUNCTION IN 478 HYPOGONADAL MEN WITH MODERATE TO SEVERE ED WITH AND WITHOUT TESTOSTERONETHERAPY FOR UP TO …[/b]A Haider, KS Haider, G Doros, A Traish - The Journal of Urology, 2018
METHODS 478 men with testosterone≤ 350 ng/dL and hypogonadal symptoms had
moderate to severe ED according to IIEF-EF (5+ 1, maximum score: 30). 246
received testosterone undecanoate injections (TU) 1000 mg/12 weeks following an …
[h=3][PDF] MP85-15 TESTOSTERONE TREATMENT IN MEN WITH CLASSICAL VS FUNCTIONAL HYPOGONADISM: RESULTS FROM A 9-YEAR-REGISTRY[/b]M Zitzmann, E Nieschlag, A Traish, S Kliesch - The Journal of Urology, 2018
METHODS Registry data of max. 9 years comprising 650 patients with
hypogonadism including 266 men with primary (mean age 34.0±11.7 years), 196
with secondary (mean age 31.9±12.0 years) and 188 with functional hypogonadism …
[h=3][PDF] PD62-05 BRIDGING THE GAP BETWEEN LOW TESTOSTERONE AND PROSTATE INFLAMMATION IN HYPOGONADAL MEN[/b]A Gabrielson, A Reddy, A Sholl, L Alzweri… - The Journal of Urology, 2018
METHODS Twenty prostate specimens from patients (10 hypogonadal, 10
eugonadal) were stained for p65 (NF-? B) and TGF-β receptor (TGF-βR) expression.
Patients were stratified by pre-RP testosterone:< 300 ng/dL as hypogonadal,> 400 …
[h=3][PDF] MP85-14 VARIANCE IN PEAK AND TROUGH TESTOSTERONE LEVELS IN MEN USING INTRAMUSCULAR TESTOSTERONE[/b]B Nascimento, HL Bernie, E Schofield, JP Mulhall - The Journal of Urology, 2018
METHODS Patients with 3 consecutive Tp and Tt levels available, while on a stable
dose and interval of IM T cypionate were analyzed. All patients were instructed as
follows: Tp levels to checked 18 hours after IM T injection, and Tt levels to be drawn …
[h=3]MP85-06 TOREMIFENE CITRATE IMPROVES HIGH-DENSITY LIPOPROTEIN LEVELS IN MEN ON TESTOSTERONE REPLACEMENT THERAPY[/b]DJ Mazur, TP Kohn, A Perez-Orozco, JA McBride… - The Journal of Urology, 2018
METHODS Men on TTh with low HDL levels (< 39 mg/dL) at a single andrology clinic
treated between October 2015 and August 2017 with either toremifine (60 mg daily),
niacin (titrated to 1,000 mg daily over 2 months) plus krill oil (1,000 mg daily)(NKO) …
[h=3]MP80-20 USE OF NON-TESTOSTERONE BASED HORMONE THERAPIES AMONG PRIVATELY INSURED US MEN, 2009-2015[/b]M Henry, D Patil, A Nangia, A Mehta - The Journal of Urology, 2018
METHODS We used 2009-2015 Truven Health MarketScan Data to identify men
using T & non-T hormone therapies (clomiphene citrate, aromatase inhibitors, human
chorionic gonadotropin (hCG), & follicle stimulating hormone (FSH)), using National …
METHODS 478 men with testosterone≤ 350 ng/dL and hypogonadal symptoms had
moderate to severe ED according to IIEF-EF (5+ 1, maximum score: 30). 246
received testosterone undecanoate injections (TU) 1000 mg/12 weeks following an …
[h=3][PDF] MP85-15 TESTOSTERONE TREATMENT IN MEN WITH CLASSICAL VS FUNCTIONAL HYPOGONADISM: RESULTS FROM A 9-YEAR-REGISTRY[/b]M Zitzmann, E Nieschlag, A Traish, S Kliesch - The Journal of Urology, 2018
METHODS Registry data of max. 9 years comprising 650 patients with
hypogonadism including 266 men with primary (mean age 34.0±11.7 years), 196
with secondary (mean age 31.9±12.0 years) and 188 with functional hypogonadism …
[h=3][PDF] PD62-05 BRIDGING THE GAP BETWEEN LOW TESTOSTERONE AND PROSTATE INFLAMMATION IN HYPOGONADAL MEN[/b]A Gabrielson, A Reddy, A Sholl, L Alzweri… - The Journal of Urology, 2018
METHODS Twenty prostate specimens from patients (10 hypogonadal, 10
eugonadal) were stained for p65 (NF-? B) and TGF-β receptor (TGF-βR) expression.
Patients were stratified by pre-RP testosterone:< 300 ng/dL as hypogonadal,> 400 …
[h=3][PDF] MP85-14 VARIANCE IN PEAK AND TROUGH TESTOSTERONE LEVELS IN MEN USING INTRAMUSCULAR TESTOSTERONE[/b]B Nascimento, HL Bernie, E Schofield, JP Mulhall - The Journal of Urology, 2018
METHODS Patients with 3 consecutive Tp and Tt levels available, while on a stable
dose and interval of IM T cypionate were analyzed. All patients were instructed as
follows: Tp levels to checked 18 hours after IM T injection, and Tt levels to be drawn …
[h=3]MP85-06 TOREMIFENE CITRATE IMPROVES HIGH-DENSITY LIPOPROTEIN LEVELS IN MEN ON TESTOSTERONE REPLACEMENT THERAPY[/b]DJ Mazur, TP Kohn, A Perez-Orozco, JA McBride… - The Journal of Urology, 2018
METHODS Men on TTh with low HDL levels (< 39 mg/dL) at a single andrology clinic
treated between October 2015 and August 2017 with either toremifine (60 mg daily),
niacin (titrated to 1,000 mg daily over 2 months) plus krill oil (1,000 mg daily)(NKO) …
[h=3]MP80-20 USE OF NON-TESTOSTERONE BASED HORMONE THERAPIES AMONG PRIVATELY INSURED US MEN, 2009-2015[/b]M Henry, D Patil, A Nangia, A Mehta - The Journal of Urology, 2018
METHODS We used 2009-2015 Truven Health MarketScan Data to identify men
using T & non-T hormone therapies (clomiphene citrate, aromatase inhibitors, human
chorionic gonadotropin (hCG), & follicle stimulating hormone (FSH)), using National …
